Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Catalyst Biosciences Inc buy stratec

Catalyst Biosciences Inc
Start price
€3.48
08.12.17 / 50%
Target price
€8.57
19.01.18
Performance (%)
146.76%
End price
€8.59
19.01.18
Summary
This prediction ended on 19.01.18 with a price of €8.59. With a performance of 146.76% the BUY prediction by stratec was a big success. stratec has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Catalyst Biosciences Inc - - - -
iShares Core DAX® 0.437% 5.897% 8.047% 65.579%
iShares Nasdaq 100 1.057% 0.920% 28.466% 90.185%
iShares Nikkei 225® 1.769% 1.228% 47.574% 84.991%
iShares S&P 500 0.368% 1.920% 23.200% 70.760%

Comments by stratec for this prediction

In the thread Catalyst Biosciences Inc diskutieren
Prediction Buy
Perf. (%) 146.76%
Target price 17.138
Change
Ends at 19.01.18

stratec stimmt der Buy-Einschätzung von melinda zu

stratec stimmt am 08.12.2017 der Buy-Einschätzung von melinda mit dem Kursziel 5,8$ zu.
Überschrift: pharma


  • Catalyst Biosciences (NASDAQ:CBIO) initiated with Buy rating and $19 (166% upside) price target by B. Riley FBR.



stratec 
0
Report Share
08.12.17
Prediction Buy
Perf. (%) 146.76%
Target price 17.138
Change
Ends at 19.01.18

(Vom Mitglied beendet)

stratec 
0
Report Share
19.01.18